Prof. Dr. Stephen J. Lewis
Professor of Pediatrics & Pharmacology
Case Western Reserve University, USA
🎓 Academic & Research Profile
- Ph.D. in Pharmacology – University of Melbourne (1982)
- Professor of Pediatrics – Case Western Reserve University (2013–Present)
- Adjunct Professor of Pharmacology – CWRU (2014–Present)
- Co-founder & CSO – Atelerix Life Sciences, Artha Biolectronics, Proove Genomics
- Editor-in-Chief – Journal of Pharmaceutical and Pharmacology Research
- NIH-funded researcher with 250+ publications and multiple patents
🔬 Research Interests
- Opioid-induced respiratory depression and addiction reversal
- Cardiovascular and ventilatory physiology
- Neuropharmacology and autonomic regulation
- Development of thiol-based therapeutics and neuromodulation strategies
📘 Teaching & Mentorship
- Extensive teaching experience at University of Iowa, Georgia, Virginia, and CWRU
- Developed 3D instructional movies for biomedical education
- Directed numerous Ph.D. and M.Sc. theses across institutions
- Consistently rated above 4.5/5.0 in student evaluations
📝 Editorial & Professional Service
- Editor-in-Chief – JPPR (IF: 6.02)
- Editorial roles in Frontiers in Pharmacology, Neuroscience, and Pharmaceuticals
- Reviewer for 30+ journals including Circulation Research, Hypertension, and Plos One
- Organizer of national symposia on opioid crisis and cardiovascular research
💰 Grants & Funding
- NIH R01, R21, U01, and SPARC grants totaling over $25 million
- Research on Sudaxine, L-NAC, and D-cysteine analogues for opioid reversal
- Collaborations with Kent State, University of Rochester, and Jackson Labs
📄 Patents
- US Patent 10,080,732 – Stimulating Ventilatory Drive (licensed by Atelerix)
- Multiple patents on thiol-based compounds and neuromodulation devices
📚 Selected Publications
Prof. Lewis has authored over 250 peer-reviewed articles in journals such as *Hypertension*, *Neuropharmacology*, *Scientific Reports*, and *Frontiers in Pharmacology*. His work spans cardiovascular regulation, opioid pharmacology, and translational therapeutics.